| Aktie | Ticker | Breite | GCS | 2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 389.759.662 $ | +114.980.506 $ | +100,8 % | 6 | 278.650.519 $ | -39.167.199 $ | -28,2 % | 8 | 320.095.902 $ | +46.257.911 $ | +78,3 % | 6 | 298.471.395 $ | +88.372.458 $ | +37,8 % | 10 | ||||
| RHYTHM PHARMACEUTICALS, INC. | RYTM | → 0 | Schwach | 131.681.580 $ | +24.951.996 $ | +23,4 % | 1 | 106.729.584 $ | +524.496 $ | +0,5 % | 1 | 106.205.088 $ | +29.078.318 $ | +37,7 % | 1 | 77.126.770 $ | +10.145.370 $ | +15,1 % | 1 |
| ARGENX SE | ARGX | → 0 | 121.800.429 $ | +10.072.179 $ | +9,0 % | 1 | 111.728.250 $ | -7.686.650 $ | -6,4 % | 1 | 119.414.900 $ | +8.780.900 $ | +7,9 % | 1 | 110.634.000 $ | +27.963.678 $ | +33,8 % | 1 | |
| Revolution Medicines, Inc. | RVMD | → 0 | Neutral | 76.850.910 $ | +51.318.992 $ | +201,0 % | 1 | 25.531.918 $ | -3.938.582 $ | -13,4 % | 1 | 29.470.500 $ | +6.480.090 $ | +28,2 % | 1 | 22.990.410 $ | +12.689.210 $ | +123,2 % | 1 |
| CYTOKINETICS INC | CYTK | → 0 | Neutral | 40.465.250 $ | +28.601.450 $ | +241,1 % | 1 | 11.863.800 $ | +1.263.867 $ | +11,9 % | 1 | 10.599.933 $ | +8.534.151 $ | +413,1 % | 1 | 2.065.782 $ | +2.065.782 $ | 1 | |
| Disc Medicine, Inc. | IRON | → 0 | Neutral | 17.562.743 $ | -766.361 $ | -4,2 % | 1 | 18.329.104 $ | -17.642.991 $ | -49,0 % | 1 | 35.972.095 $ | +7.557.695 $ | +26,6 % | 1 | 28.414.400 $ | +14.380.000 $ | +102,5 % | 1 |
| CORCEPT THERAPEUTICS INC | CORT | → 0 | Neutral | 18.433.386 $ | -14.173.243 $ | -43,5 % | 1 | 32.606.629 $ | +7.363.121 $ | +29,2 % | 1 | ||||||||
| Crinetics Pharmaceuticals, Inc. | CRNX | → 0 | Schwach | 1.461.154 $ | -9.367.846 $ | -86,5 % | 1 | 10.829.000 $ | +10.829.000 $ | 1 | |||||||||
| Septerna, Inc. | SEPN | → 0 | Neutral | 2.410.209 $ | -2.915.993 $ | -54,7 % | 1 | 5.326.202 $ | -872.818 $ | -14,1 % | 1 | ||||||||
| Stoke Therapeutics, Inc. | STOK | → 0 | Neutral | 4.983.152 $ | +4.983.152 $ | 1 | |||||||||||||
| Kymera Therapeutics, Inc. | KYMR | → 0 | Neutral | 3.495.050 $ | -1.174.037 $ | -25,1 % | 1 | ||||||||||||
| Trevi Therapeutics, Inc. | TRVI | → 0 | Neutral | 1.398.750 $ | +802.250 $ | +134,5 % | 1 | 596.500 $ | +596.500 $ | 1 | |||||||||
| 389.759.662 $ | +114.980.506 $ | +100,8 % | 6 | 278.650.519 $ | -39.167.199 $ | -28,2 % | 8 | 320.095.902 $ | +46.257.911 $ | +78,3 % | 6 | 298.471.395 $ | +88.372.458 $ | +37,8 % | 10 | ||||